Advanced Science, EarlyView.ABSTRACT Tumor immune escape is a major barrier to durable cancer immunotherapy, as advanced malignancies create a tumor microenvironment (TME) that preferentially exhausts and disables T cell responses. While most approved cell therapies are T cell‐based, this limitation motivates the exploration of an alternative effector cell platform.
Tereza Kochs +4 more
wiley +1 more source
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038). [PDF]
TrialsIsnard S +14 more
europepmc +1 more source
Advanced Science, EarlyView.A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang +8 more
wiley +1 more source
Overcoming phagocytosis resistance of hypervirulent <i>Klebsiella pneumoniae</i> by directly targeting capsules. [PDF]
Microb CellTsubaki S +6 more
europepmc +1 more source
Washed microbiota transplantation: candidates for a novel strategy for ameliorating autism spectrum disorder. [PDF]
Front MicrobiolFeng S +9 more
europepmc +1 more source
Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial. [PDF]
Nat CommunPanah FM +11 more
europepmc +1 more source
Tinea incognito skin lesions worsen after antifungal treatment: Atypical tinea appearing twice in a case: A case report. [PDF]
Medicine (Baltimore)Zhang N, Zhang R.
europepmc +1 more source
Decolonizing the gut from multidrug-resistant bacteria: Current strategies and future perspectives. [PDF]
World J MethodolMishra A, Juneja D.
europepmc +1 more source